RT Book, Section
A1 Ma, Joseph D.
A1 Lewis, Karen E.
A1 Bertino, Joseph S.
A2 Bertino, Joseph S.
A2 DeVane, C. Lindsay
A2 Fuhr, Uwe
A2 Kashuba, Angela D.
A2 Ma, Joseph D.
SR Print(0)
ID 56875566
T1 Chapter 5. Ethical, Legal, and Social Issues Associated with Pharmacogenomics
T2 Pharmacogenomics: An Introduction and Clinical Perspective
YR 2013
FD 2013
PB The McGraw-Hill Companies
PP New York, NY
SN 978-0-07-174169-9
LK accesspharmacy.mhmedical.com/content.aspx?aid=56875566
RD 2024/04/20
AB To  identify  the  current  ethical,  legal,  and  social  issues  associated  with  pharmacogenomics  and  pharmacogenomic  testing.To  understand  how  genetic  discrimination,  stigmatization,  and  privacy  and  confidentiality  impact  the  implementation  of  pharmacogenomic  testing  into  clinical  practice.To  understand  the  legal  issues  involving  pharmacogenomic  testing  regarding  the  ownership  of  data  and/or  samples  and  intellectual  property.To  develop  a  knowledge  base  involving  pharmacogenomic  core  competencies.